Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts

Field Value
Model ID13-016-01
Model NameR2CHADS2
Pubmed ID23212720
First AuthorPiccini
JournalCirculation
Year2013
TitleRenal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts
Primary Index ConditionArrhythmia
Secondary Index ConditionNOS
OutcomeStroke
Model Sample Size14171
Cohort Sample Size14264
Number of Events575
Follow-Up DurationLong (> 6 months)
AUROC0.635
Calibration Reported1
CovariatesTo be updated
Mesh TermsTo be updated
Number of Validations7

External Validations

Yes
7
0.672
1st Author Year Sample Size AUC Calibration Relatedness
Bautista 2015 98 0.631 No To be updated
Peguero 2016 2263 0.64 No To be updated
Abumuaileq 2015 154 0.65 No To be updated
To be updated To be updated 13559 0.672 No To be updated
Abumuaileq 2015 911 0.7 No To be updated
Bautista 2015 524 0.718 No To be updated
Bautista 2015 426 0.724 No To be updated